Jingsi Dong

1.3k total citations · 1 hit paper
29 papers, 501 citations indexed

About

Jingsi Dong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jingsi Dong has authored 29 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jingsi Dong's work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Jingsi Dong is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Jingsi Dong collaborates with scholars based in China, United States and Australia. Jingsi Dong's co-authors include Bingjie Li, Dan Lin, Depei Huang, Qinghua Zhou, Jiagen Li, Jie He, Zhaoli Chen, Qinghua Zhou, Canhua Huang and Edouard C. Nice and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Gene.

In The Last Decade

Jingsi Dong

28 papers receiving 495 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Redox regulation: mechanisms, biology and therapeutic targets in diseases

2025 71 citations Bowen Li, Hui Ming et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Jingsi Dong

Since Specialization

Citations

This map shows the geographic impact of Jingsi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsi Dong more than expected).

Fields of papers citing papers by Jingsi Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingsi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsi Dong. The network helps show where Jingsi Dong may publish in the future.

Co-authorship network of co-authors of Jingsi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Jingsi Dong. A scholar is included among the top collaborators of Jingsi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingsi Dong. Jingsi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Redox regulation: mechanisms, biology and therapeutic targets in diseases breakdown → 2025 ·Signal Transduction and Targeted Therapy ·Bowen Li, Hui Ming, Siyuan Qin, Edouard C. Nice, Jingsi Dong, Zhongyan Du, Canhua Huang	71
2	2025P Stratified control study of neuroendocrine differentiation and potential clinicopathologic markers 2023 ·Annals of Oncology ·Li Liu, (unknown), Jingsi Dong, Puyuan Xing, Junjie Li, Jianming Ying, Lu Yang	1
3	Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report 2023 ·Thoracic Cancer ·Jindong Chen, Ling You, Jingsi Dong	2
4	Combination of STING agonist and CXCR3 antagonist disrupts immune tolerance to overcome anti-PD-L1 resistance in lung adenocarcinoma under oxidative stress 2022 ·Gene ·Lingling Zhu, (unknown), Shiqi Huang, Ting Cao, Xiaoqian Zhai, Jia Hu, Ting Wang, Jingsi Dong, Zelong Liu, Chen Jiang, Jiewei Liu, Zhirong Zhang, Qinghua Zhou	6
5	Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma 2020 ·Genomics ·Rui Li, Jingsi Dong, (unknown), Qi Zhao, Xingyang Li, Xuefei Liu, Ying Ye, Shuang Deng, Dongxin Lin, Jian Zheng, Zhixiang Zuo	4
6	Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov 2020 ·Frontiers in Oncology ·Jingsi Dong, (unknown), Dan Lu, Bingjie Li, (unknown), Dan Lin, Yonggang Zhang	24
7	LincRNA00494 Suppresses Non-small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression as a ceRNA 2020 ·Frontiers in Oncology ·Jingsi Dong, Bingjie Li, Dan Lin, Dan Lu, Chang Liu, (unknown), Xiaojun Tang, Lu Li, Daxing Zhu, Jiewei Liu, Xiaoming Qiu, (unknown), Qinghua Zhou	10
8	Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients 2019 ·Frontiers in Oncology ·Jingsi Dong, Daxing Zhu, Xiaojun Tang, Xiaoming Qiu, Dan Lu, Bingjie Li, Dan Lin, Qinghua Zhou	28
9	Precise Prediction of Calpain Cleavage Sites and Their Aberrance Caused by Mutations in Cancer 2019 ·Frontiers in Genetics ·Zexian Liu, Kai Yu, Jingsi Dong, Linhong Zhao, Zekun Liu, Qingfeng Zhang, (unknown), (unknown), Han Cheng	28
10	Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer 2019 ·PLoS ONE ·Jingsi Dong, Daxing Zhu, Xiaojun Tang, Dan Lü, Xiaoming Qiu, Bingjie Li, Dan Lin, Lu Li, Jiewei Liu, Qinghua Zhou	13
11	Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing 2019 ·Frontiers in Pharmacology ·Jingsi Dong, Bingjie Li, Dan Lin, Qinghua Zhou, Depei Huang	83
12	Comparison and correlation between the pediatric Voice Handicap Index and the pediatric voice-related quality-of-life questionnaires 2018 ·Medicine ·(unknown), Mengjie Huang, Ivy Cheng, Jingsi Dong, Hui Yang	10
13	Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung 2018 ·Thoracic Cancer ·(unknown), (unknown), Daxin Zhu, (unknown), Jingsi Dong, Xiaoming Qiu, Mingyu Fan, (unknown), Xiaojun Tang	12
14	[Comparison of the lymph node dissection and complications between video-assisted thoracoscopic (VATS) esophagectomy and conventional esophagectomy via right thoracotomic]. 2015 ·PubMed ·Yousheng Mao, Jie He, (unknown), Jingsi Dong, Shugeng Gao, Kelin Sun, (unknown), (unknown), Qi Xue, Xiangyang Liu, Dekang Fang, Dali Wang, Jun Zhao, Jian Li, Yonggang Wang, Yushun Gao, Jinfeng Huang	2
15	Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer 2015 ·Cancer Letters ·Chengcheng Zhou, Zhaoli Chen, Jingsi Dong, Jiagen Li, Xuejiao Shi, Nan Sun, (unknown), Fang Zhou, Fengwei Tan, Jie He	28
16	Endotracheal and Endobronchial Metastases in a Patient With Stage I Lung Adenocarcinoma 2014 ·The Annals of Thoracic Surgery ·Zhirong Zhang, Yousheng Mao, Huang Chen, Jingsi Dong, Longhai Yang, Lei Zhang, Fang Wang	9
17	Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer 2013 ·Translational Oncology ·Yue Yu, Zhaoli Chen, Jingsi Dong, Wei Peng, (unknown), Chengcheng Zhou, Nan Sun, Mei Luo, Wenjing Yang, Ran Yao, Yibo Gao, Jiagen Li, Guohua Yang, Wei He, Jie He	94
18	[Comparison of the results of lymph node dissection via left versus right thoracotomy]. 2012 ·PubMed ·Yousheng Mao, Jie He, Jingsi Dong, (unknown), Kelin Sun, Xiangyang Liu, Dekang Fang, (unknown), Yonggang Wang	7
19	Cardiopulmonary exercise testing in the evaluation of high risk patients with lung cancer. 2010 ·PubMed ·Yousheng Mao, Jie He, (unknown), Jingsi Dong, (unknown), Kelin Sun, Xiangyang Liu, (unknown), (unknown), (unknown), Jinfeng Huang	8
20	[Amplification and overexpression of c-erbB2 in human breast cancer]. 1995 ·PubMed ·(unknown), Jingsi Dong, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact